Rtw Investments, LP Avidity Biosciences, Inc. Transaction History
Rtw Investments, LP
- $6.27 Billion
- Q3 2024
A detailed history of Rtw Investments, LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 8,132,870 shares of RNA stock, worth $336 Million. This represents 5.95% of its overall portfolio holdings.
Number of Shares
8,132,870
Previous 8,806,838
7.65%
Holding current value
$336 Million
Previous $360 Million
3.83%
% of portfolio
5.95%
Previous 6.01%
Shares
9 transactions
Others Institutions Holding RNA
# of Institutions
256Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$439 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$381 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$356 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$290 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.88MShares$284 Million4.75% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.15B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...